| 1 | The Multifaceted Role of Bilirubin in Liver Disease: A Literature Review | Coautor: Pal, SC, Ramírez-Mejía, MM, Castillo-Castañeda, SM, Qi, XS, et al. | 2024 | Journal Of Clinical And Translational Hepatology | WoS-id: 001338340300001
| 4 | 0 |
| 2 | MAFLD: perceived stigma?a single-center Mexican patient survey | 2ᵒ autor: Pal S.C., Méndez-Sánchez N., Fassio E., Díaz-Ferrer J., et al. | 2023 | HEPATOLOGY INTERNATIONAL | WoS-id: 000894544400002
Scopus-id: 2-s2.0-85143440740
| 9 | 9 |
| 3 | Interpretive bias on research evidence: Striving to meet the trustworthiness criteria | Coautor y autor de correspondencia: Pal, Shreya C., Mendez-Sanchez, Nahum, Fassio, Eduardo | 2023 | Annals Of Hepatology | WoS-id: 000899935000001
Scopus-id: 2-s2.0-85145691527
| 0 | 0 |
| 4 | How far are we from an approved drug for nonalcoholic steatohepatitis? | 2ᵒ autor: Pal S.C., Méndez-Sánchez N., Córdova-Gallardo J. | 2023 | EXPERT OPINION ON PHARMACOTHERAPY | WoS-id: 000979181200001
Scopus-id: 2-s2.0-85158817329
| 3 | 2 |
| 5 | Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis | 1ᵉʳ autor: Pal, Shreya C., Mendez-Sanchez, Nahum | 2023 | WORLD JOURNAL OF GASTROENTEROLOGY | WoS-id: 001032674900004
Scopus-id: 2-s2.0-85164987251
| 25 | 26 |
| 6 | Screening for MAFLD: who, when and how? | 1ᵉʳ autor: Pal, Shreya C., Mendez-Sanchez, Nahum | 2023 | Therapeutic Advances in Endocrinology and Metabolism | WoS-id: 001061086400001
Scopus-id: 2-s2.0-85147034404
| 16 | 16 |
| 7 | Molecular Mechanisms Involved in MAFLD in Cholecystectomized Patients: A Cohort Study | 1ᵉʳ autor: Pal, Shreya C., Castillo-Castaneda, Stephany M., Diaz-Orozco, Luis E., Ramirez-Mejia, Mariana M., et al. | 2023 | GENES | WoS-id: 001093717500001
Scopus-id: 2-s2.0-85175272849
| 1 | 2 |
| 8 | Editorial: Acute Hepatitis of Unknown Origin in Children. Is Autoimmunity at Play? | 2ᵒ autor y autor de correspondencia: Pal S.C., Mendez-Sanchez N. | 2022 | MEDICAL SCIENCE MONITOR | WoS-id: 000811725500001
Scopus-id: 2-s2.0-85132080107
| 5 | 8 |
| 9 | Detangling the interrelations between MAFLD, insulin resistance, and key hormones | 1ᵉʳ autor: Pal, Shreya C., Eslam, Mohammed, Mendez-Sanchez, Nahum | 2022 | HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM | WoS-id: 000835599300001
Scopus-id: 2-s2.0-85135341662
| 26 | 30 |
| 10 | Identification of Hepatic Dendritic Cells in Liver Biopsies Showing Steatosis in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Associated with Obesity | 2ᵒ autor: Pal, Shreya C., Barranco-Fragoso, Beatriz, Diaz-Orozco, Luis E., Dorantes-Heredia, Rita, et al. | 2022 | MEDICAL SCIENCE MONITOR | WoS-id: 000841909000001
Scopus-id: 2-s2.0-85135549674
| 8 | 8 |
| 11 | Correction to: Detangling the interrelations between MAFLD, insulin resistance, and key hormones (Hormones, (2022), 21, 4, (573-589), 10.1007/s42000-022-00391-w) | 1ᵉʳ autor: Pal, Shreya C., Eslam, Mohammed, Mendez-Sanchez, Nahum | 2022 | HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM | WoS-id: 000846799600001
Scopus-id: 2-s2.0-85136631968
| 0 | 0 |
| 12 | Editorial: Treatment with Dual Incretin Receptor Agonists to Maintain Normal Glucose Levels May Also Maintain Normal Weight and Control Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) | Coautor: Pal, Shreya C., Ordóñez-Vázquez A.L., Beltrán-Gall S.M., Mendez-Sanchez, Nahum | 2022 | MEDICAL SCIENCE MONITOR | WoS-id: 000861215900002
Scopus-id: 2-s2.0-85137658129
| 7 | 9 |
| 13 | New terms for fatty liver disease other than MAFLD: Time for a reality check | 2ᵒ autor y autor de correspondencia: Pal, Shreya C., Mendez-Sanchez, Nahum | 2022 | JOURNAL OF HEPATOLOGY | WoS-id: 000899473900021
Scopus-id: 2-s2.0-85141673462
| 2 | 4 |